- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03964467
Priming With tDCS: Expanding the Window of Recovery in Chronic Stroke
Investigation of Central Priming Prior to Training of the Upper Extremity in Chronic Stroke
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
AIM 1: To determine if UE motor performance significantly improves in individuals with moderate impairment from chronic stroke, following anodal tDCS applied to the ipsilesional PMd during circuit-based, UE, TRT conducted three times/week for 4-weeks. Hypothesis: Following a 4-week, tDCS-paired UE TRT program, there will be significant changes in unimanual and bimanual performance in individuals with moderate impairment from chronic stroke, as detected by clinical assessments. Our primary measure will be UE accelerometry gathered with wrist-based ActiGraphs; a secondary measure will be the Wolf Motor Function Test (WMFT).
AIM 2: To determine if there are significant structural and functional brain changes in individuals with moderate impairment from chronic stroke, following anodal tDCS applied to the ipsilesional PMd paired with circuit-based, UE, TRT conducted 3 times/week for 4-weeks. Hypothesis: Following a 4-week, tDCS-paired UE TRT program, there will be significant structural/functional brain changes as detected by magnetic resonance imaging (MRI) and functional MRI (fMRI). Based on prior work,4,10 we expect that there will be an increase in resting state functional connectivity as shown using BOLD fMRI between the cerebellum and cortical areas.
Task related training (TRT) is a treatment approach that aims to increase use of the paretic arm, avoid learned disuse and minimize compensation (Thielman et al, 2004). It involves variable practice of goal-directed, functional movements in a natural environment (Ada et al, 1994) focusing on solving movement problems (Gentile, 2000). Task related training has been found to significantly improve paretic arm function post-stroke, in individuals with baseline UE FM < 35 (Kim et al., 2013; Thielman et al., 2004; Thielman, 2015; Wu et al, 2000).
The effects of TRT could be augmented with noninvasive brain stimulation pairing. Motor priming before or during task practice has been found to foster motor learning and UE function in healthy individuals and persons post-stroke by increasing neuroplasticity (Fusco et al., 2014; Stoykov and Madhavan, 2015; Stoykov and Stinear, 2010). Anodal transcranial direct current stimulation (tDCS) is one form of stimulation (Fusco et al., 2014). Anodal tDCS increases neuronal excitability by depolarizing the membrane potential while cathodal tDCS decreases excitability and hyperpolarizes the membrane potential (Nitsche and Paulus, 2001). After effects from anodal tDCS stimulation, involving activation of NDMA receptors associated with long-term potentiation, have been shown to last up to 120 minutes (min) (Madhavan and Shah, 2012). Anodal tDCS administered during intervention has a greater impact on UE function than therapy or tDCS alone (Bolognini et al., 2011; Butler et al., 2013; Cho et al., 2015; Lee and Lee, 2015; Yao et al., 2015). While the receipt of tDCS during therapeutic interventions is promising, it can limit the therapy to seated or more sedentary programs. Given the support in the literature, we believe it may be more effective to foster neuroplasticity and UE functional recovery in chronic stroke survivors if tDCS is done repetitively, during participation in a dynamic UE standing program. Our circuit-based, UE TRT standing program requires more aerobic effort from participants than seated programming and greater aerobic effort has been shown to foster neuroplasticity in persons post-stroke (Mang et al., 2013; Quaney et al., 2009).
Expanding Plasticity Beyond the Motor Cortex. The dorsal premotor cortex (PMd) may be a more suitable neural substrate for promoting recovery in moderately impaired individuals. While the results of anodal priming over the ipsilesional motor cortex are promising, the effects have primarily been limited to persons with mild impairments. For persons with moderate impairment, a substantial portion of the motor cortex and/or corticospinal system is damaged leaving less neural substrate within M1 than can be targeted using anodal tDCS. In such individuals, alternative cortical sites may have greater potential to reorganize and implement motor recovery. Previously, we (Kantak et. al., 2012) and others (Plow et al., 2016) proposed that the PMd may be uniquely poised to reorganize and implement recovery after motor cortex injury. The PMd contributes to over 30% of descending corticospinal fibers (Barbas and Pandya, 1987; Dum and Strick, 2002). Further, the PMd has been shown to reorganize after stroke, contributing to motor performance (Fridman et al., 2004; Kantak et al., 2012; Mohapatra et al., 2016). We believe that the benefit of priming the PMd before engaging in circuit-based, UE TRT warrants further investigation.
Brain Imaging. Using hybrid diffusion magnetic resonance imaging (MRI) and functional MRI (fMRI) to quantify structural and functional changes in the brain is critical to understand behavioral change post-injury and with training. Functional organization of intact cortical tissue post-stroke is dependent on the post-injury behavioral experience (O'Shea et al, 2007). Neuroimaging has been used to show an increase in neural activity in persons who engage in TRT post-stroke (Nelles et al,2001). By using fMRI to assess brain function, the volume of activation in regional brain areas can be determined, which could be used to predict treatment outcome (Cramer, 2008).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of the Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- > 18-75 years of age;
- diagnosis of ≥ 1 stroke > 6 months before participation;
- in good health;
- classified with moderate impairment based on the UE Fugl Meyer Assessment (FMA; score of 19-47
- safe for the MRI environment;
- able to elevate and hold the paretic arm for 2 seconds at 90 degs shoulder elevation, 160-180O elbow extension and neutral forearm supination;
- ≥ 20 degrees gravity minimized wrist extension while holding a cylindrical object on a tabletop.
Exclusion Criteria:
- bone or joint limitations that restrict paretic arm motion;
- history of skull fractures or burr hole(s);
- resting heart rate and resting blood pressure outside the range of 40-100 beats/min and 90/60 to 170/90 mm Hg respectively;
- chest pain or shortness of breath at rest;
- history epilepsy or seizures;
- Botox injections to the paretic arm within 4 months of participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Experimental
Transcranial Direct Current Stimulation.1)
Scalp measurements of the scalp will be taken using the 10-20 EEG measurement system to determine anode and cathode placement.
2) One 1x1 Bicarbon electrode with wires attached will be placed in the center of each 5 cm x 7 cm sponge electrode dampened with 8 ml of saline.
3) One sponge electrode will be placed over the ipsilesional PMd (F3) and the other sponge electrode over the contralesional supraorbital region(Fp2).
4) Each sponge electrode will be secured under the plastic EZ strap 5) The current from the Actividose II will be turned up to 2 MA.
The current will ramp up/down in 15 seconds.
We will observe for adverse effects and hit the pause button, then turn the machine off, if a participant does not tolerate the stimulation.
Individuals in this arm will have the stimulation stay in current until the full dose is delivered.
Each participant will then engage in the UE TRT as outlined below.
|
see arm/group descriptions
Other Names:
|
SHAM_COMPARATOR: Control
Individuals in this arm will have the stimulation cycled off after 2-3 minutes.
All will be part of the Circuit-Based, UE Task Related Training.
Each participant will engage in the training program for 1.5 hours; rotating through 5 stations at about 15 minute intervals, participating in standing as tolerated, but stations can be adapted to sitting.
The goal is for each participant perform > 225 movements with the affected arm per session, at the highest functional level.
Rest breaks given as needed.
Examples of stations are: Reach-to-grasp tasks to objects of various weight, texture and dimension at different distances and table heights.
Practice opening simulated locks and containers.
Shoulder wheel involving grasping plastic plates with varied grip patterns and sliding them up and over the wheel from the unaffected to the affected side encouraging shoulder abduction, external rotation and supination.
Bimanual/unimanual ball toss: catching, releasing.
|
see arm/group descriptions
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
UE Accelerometry
Time Frame: 3 day period prior to training
|
actigraph markers placed on each arm
|
3 day period prior to training
|
UE Accelerometry
Time Frame: 3 day period post training to assess change- more activity inbdicates greater overall use
|
actigraph markers placed on each arm
|
3 day period post training to assess change- more activity inbdicates greater overall use
|
Functional MRI
Time Frame: within 3 days prior to training
|
fMRI consisting of structural data collected, DTI, resting state data functional task data
|
within 3 days prior to training
|
Functional MRI
Time Frame: within 3 days post training to measure change- increased activity in designated areas explains pattern of neuroplasticity
|
fMRI consisting of structural data collected, DTI, resting state data and functional task data
|
within 3 days post training to measure change- increased activity in designated areas explains pattern of neuroplasticity
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body Structure Function and Impairment Data
Time Frame: 1-3 days prior to training start
|
Impairment measures- FMA
|
1-3 days prior to training start
|
Body Structure Function and Impairment Data
Time Frame: 1-3 days post training
|
Impairment measures- FMA (19-47.
with higher scores indicating positive change)
|
1-3 days post training
|
Body Structure Function and Impairment Data
Time Frame: 1-3 days prior to training start
|
Impairment measures- grip strength (0-60 Kg, with higher scores indicating increased strength
|
1-3 days prior to training start
|
Body Structure Function and Impairment Data
Time Frame: 1-3 days post training
|
Impairment measures- grip strength
|
1-3 days post training
|
Body Structure Function and Impairment Data
Time Frame: 1-3 days prior to training start
|
Impairment measures- AROM
|
1-3 days prior to training start
|
Body Structure Function and Impairment Data
Time Frame: 1-3 days post training
|
Impairment measures- AROM (elbow extension- minus 30 to 0, with 0 being full positive for full extension; shoulder flexion- 90 - 180, with greater excursion indicating greater positive progress
|
1-3 days post training
|
Body Structure Function and Impairment Data
Time Frame: 1-3 days prior to training start
|
Activity measures-Wolf Motor Function Test- time to complete task
|
1-3 days prior to training start
|
Body Structure Function and Impairment Data
Time Frame: 1-3 days post training
|
Activity measures-Wolf Motor Function Test- time to complete task indicated- with less time indicting improvement
|
1-3 days post training
|
Body Structure Function and Impairment Data
Time Frame: 1-3 days prior to training start
|
Patient Reported measure- Stroke Impact Scale-
|
1-3 days prior to training start
|
Body Structure Function and Impairment Data
Time Frame: 1-3 days post training
|
Patient Reported measure- Stroke Impact Scale- pt.reports changes on named activities participation in real world on a 1-5 point Likert scale across the 8 domains, with higher scores indicating less difficulty on the tasks
|
1-3 days post training
|
Collaborators and Investigators
Investigators
- Principal Investigator: Gregory Thielman, EdD, Professor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 06-0008
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
all fMRI data will be made available to the ENIGMA Stroke group as a member of this consortium.
The behavioral data is available publicly as able on this or any site I am directed to. Often I am contacted individually by the PI of systematic reviews for this type of data
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Upper Extremity Paresis
-
Abant Izzet Baysal UniversityEnrolling by invitationStroke | Upper Extremity Paralysis | Upper Extremity ParesisTurkey
-
Riphah International UniversityRecruitingUpper Extremity ParesisPakistan
-
Adventist HealthCareCenter for Student Research Texas Woman's UniversityRecruitingStroke | Upper Extremity ParesisUnited States
-
Adventist HealthCareTexas Woman's UniversityCompletedStroke | Upper Extremity ParesisUnited States
-
BaycrestCompletedStroke | Upper Extremity ParesisCanada
-
Ben-Gurion University of the NegevBarzilai Medical Center; Bet HadarCompletedUpper Extremity Paresis | Motor ControlIsrael
-
Weill Medical College of Cornell UniversityCompletedSurgery of Right Upper ExtremityUnited States
-
University of British ColumbiaUniversity of Toronto; Queen's University; Dalhousie University; Wings for LifeRecruitingUpper Extremity Dysfunction | Cervical Spinal Cord Injury | Spinal Cord Injury | Spinal Cord Injury at C5-C7 Level | SCI - Spinal Cord Injury | Upper Extremity Paralysis | Tetraplegia | Upper Extremity ParesisCanada
-
Rush University Medical CenterCompletedStroke, Upper Extremity HemiparesisUnited States
-
Ohio State UniversityNationwide ChildrenCompletedStroke | Upper Extremity Dysfunction | HemiparesisUnited States
Clinical Trials on transcranial direct current stimulation
-
Federal University of ParaíbaCompleted
-
Medical University of South CarolinaEunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
University of Campinas, BrazilUnknownEpilepsy IntractableBrazil
-
Dina Hatem ElhammadyUnknown
-
Shirley Ryan AbilityLabNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Nonfluent AphasiaUnited States
-
University of Texas Rio Grande ValleyRecruitingSpinal Cord Diseases | Spinal Cord InjuriesUnited States
-
Federal University of ParaíbaUnknown
-
University of CalgaryAlberta Health servicesRecruitingCervicogenic HeadacheCanada
-
Universidade Federal do Rio Grande do NorteNot yet recruitingLow Back Pain | Transcranial Direct Current Stimulation
-
Nanyang Technological UniversityActive, not recruiting